Page last updated: 2024-11-02

oxidopamine and Craniocerebral Trauma

oxidopamine has been researched along with Craniocerebral Trauma in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Craniocerebral Trauma: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaseloo, PA1
Lis, A1
Asada, H1
Barone, TA1
Plunkett, RJ1

Other Studies

1 other study available for oxidopamine and Craniocerebral Trauma

ArticleYear
In vitro assessment of neurotrophic activity from the striatum of aging rats.
    Neuroscience letters, 1996, Nov-08, Volume: 218, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Aging; Animals; Cell Extracts; Cell Line; Cells, Cultured; Chick Embryo

1996